| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | President And CEO +1 more
3 companies
Souza Marcio is a Director at Spyre Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 7 buys and 12 sells.
Estimated insider holdings value: $32.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | PRAX Praxis Precision Medicines, Inc. | Chief Executive Officer | Buy | 10,000 | $1.06 | $10,587.00 | +28.6% | +32.2% | +152.1% | |
| Mar 23, 2023 | PRAX Praxis Precision Medicines, Inc. | Chief Executive Officer | Buy | 70,002 | $0.86 | $60,366.01 | +36.6% | +28.8% | +320.6% | |
| Aug 25, 2022 | SYRE Spyre Therapeutics, Inc. | Director | Buy | 90,000 | $0.56 | $50,472.00 | New | +131.4% | 0.0% | |
| Jun 8, 2022 | PRAX Praxis Precision Medicines, Inc. | Chief Executive Officer | Buy | 27,000 | $1.85 | $49,887.90 | +16.6% | +61.1% | -43.9% | |
| Aug 18, 2021 | PRAX Praxis Precision Medicines, Inc. | Chief Executive Officer | Buy | 9,542 | $15.79 | $150,668.18 | +12.4% | +23.6% | -76.3% | |
| Nov 10, 2020 | PRAX Praxis Precision Medicines, Inc. | Chief Executive Officer | Buy | 3,846 | $26.08 | $100,303.68 | +18.7% | - | - | |
| Feb 10, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 625 | $53.92 | $33,700.00 | -8.5% | - | - | |
| Jan 23, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 154 | $53.25 | $8,200.04 | -2.9% | - | - | |
| Jan 6, 2020 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 86 | $48.17 | $4,142.45 | -1.6% | - | - | |
| Dec 23, 2019 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 102,945 | $48.90 | $5,033,731.67 | -21.6% | - | - |